Page last updated: 2024-10-22

alendronate and Hypocalcemia

alendronate has been researched along with Hypocalcemia in 11 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Hypocalcemia: Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to assess the effects of the antiresorptive treatments of alendronate (ALN), risedronate (RIS) and raloxifene (RLX) on the response of bone to endogenous parathyroid hormone (PTH) induced by acute hypocalcemia."5.14Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone. ( Stepan, JJ; Zikan, V, 2009)
"Alendronate sodium is an aminobiphosphonate, an analog of inorganic pyrophosphate, indicated for the treatment of osteoporosis in post-menopausal women."3.72Pharmacovigilance study of alendronate in England. ( Biswas, PN; Shakir, SA; Wilton, LV, 2003)
"This case report describes a patient who was previously prescribed alendronate (Fosamax) and presented with postoperative hypophosphatemia and hypocalcemic tetany after bowel preparation with Fleet Phospho-Soda."3.70Postoperative hypocalcemic tetany caused by fleet phospho-soda preparation in a patient taking alendronate sodium: report of a case. ( Badhwar, V; Campisi, P; Morin, S; Trudel, JL, 1999)
"Alendronate is a bisphosphonate which inhibits bone resorption."1.29Effects of the bisphosphonate, alendronate, on parturition in the rat. ( Manson, JM; Minsker, DH; Peter, CP, 1993)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (45.45)18.2507
2000's5 (45.45)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zikan, V1
Stepan, JJ1
Jain, SK1
Roy, SP1
Nagi, ON1
Maclsaac, RJ1
Seeman, E1
Jerums, G1
Biswas, PN1
Wilton, LV1
Shakir, SA1
Lin, JH1
Chen, IW1
deLuna, FA1
Hichens, M1
Minsker, DH1
Manson, JM1
Peter, CP1
Schussheim, DH1
Jacobs, TP1
Silverberg, SJ1
Ikeda, K1
Kawaguchi, Y1
Nakayama, M1
Yamamoto, H1
Osaka, N1
Takeyama, H1
Hosoya, T1
Campisi, P1
Badhwar, V1
Morin, S1
Trudel, JL1
Kashyap, AS1
Kashyap, S1
Stuckey, BG1
Lim, EM1
Kent, GN1
Ward, LC1
Gutteridge, DH1

Trials

1 trial available for alendronate and Hypocalcemia

ArticleYear
Marked reduction of bone turnover by alendronate attenuates the acute response of bone resorption marker to endogenous parathyroid hormone.
    Bone, 2009, Volume: 44, Issue:4

    Topics: Aged; Aged, 80 and over; Alendronate; Area Under Curve; Biomarkers; Bone Density Conservation Agents

2009

Other Studies

10 other studies available for alendronate and Hypocalcemia

ArticleYear
Alendronate induced femur fracture complicated with secondary hyperparathyroidism.
    Mymensingh medical journal : MMJ, 2011, Volume: 20, Issue:3

    Topics: Aged; Alendronate; Bone Density Conservation Agents; Female; Femoral Fractures; Humans; Hyperparathy

2011
Seizures after alendronate.
    Journal of the Royal Society of Medicine, 2002, Volume: 95, Issue:12

    Topics: Aged; Aged, 80 and over; Alendronate; Drug Administration Schedule; Female; Humans; Hypocalcemia; Os

2002
Pharmacovigilance study of alendronate in England.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2003, Volume: 14, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Alendronate; Angioedema; Cohort Studies; Erythema Multiforme; Family

2003
Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.
    The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:2

    Topics: Alendronate; Animals; Blood Proteins; Calcium; Calcium Radioisotopes; Diphosphonates; Hydrogen-Ion C

1993
Effects of the bisphosphonate, alendronate, on parturition in the rat.
    Toxicology and applied pharmacology, 1993, Volume: 121, Issue:2

    Topics: Alendronate; Animals; Calcium; Diphosphonates; Female; Fertility; Hypocalcemia; Labor, Obstetric; Ma

1993
Hypocalcemia associated with alendronate.
    Annals of internal medicine, 1999, Feb-16, Volume: 130, Issue:4 Pt 1

    Topics: Aged; Alendronate; Bone Diseases, Metabolic; Female; Humans; Hypocalcemia; Hypoparathyroidism

1999
Novel usage of alendronate to prevent profound hypocalcemia immediately after parathyroidectomy in patients with severe secondary hyperparathyroidism.
    Nephron, 1999, Volume: 83, Issue:2

    Topics: Alendronate; Calcium; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Male; Middle Aged; Parat

1999
Postoperative hypocalcemic tetany caused by fleet phospho-soda preparation in a patient taking alendronate sodium: report of a case.
    Diseases of the colon and rectum, 1999, Volume: 42, Issue:11

    Topics: Adult; Alendronate; Cathartics; Colectomy; Colonoscopy; Crohn Disease; Drug Combinations; Enema; Fem

1999
Hypoparathyroidism unmasked by alendronate.
    Postgraduate medical journal, 2000, Volume: 76, Issue:897

    Topics: Aged; Alendronate; Calcitriol; Calcium Carbonate; Calcium Channel Agonists; Female; Humans; Hypocalc

2000
Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2001, Volume: 16, Issue:9

    Topics: Alendronate; Calcitriol; Calcium; Cervical Vertebrae; Diphosphonates; Female; Humans; Hypocalcemia;

2001